Our dedicated editorial team provides thorough coverage of all biological sequence information from patents including:

• Nucleic acid sequences 10 or more bases in length
• Amino acid sequences 4 or more residues in length
• All PCR primers and probes of any length
• Sequence and contextual information, irrespective of its location within a patent, including organism name, gene/protein name, sequence modifications, associated disease information
• Non-English patents (in total, these comprise more than a third of the database), including Japanese, Chinese, Korean and European languages, with English language indexing
• Links to identical records from NCBI, SWISSPROT, Gene Ontology (GO) annotation, and sequence aliases

The team adds a unique commentary, clarifying sequence novelty and the actual utility underlying each invention. Each record is fully indexed using standardized terminology, enabling accurate search and retrieval.

This annotation includes:

• Enhanced patent titles
• English language abstract from non-English sources
• Sequence location within the patent document
• Original source organism
• Highlighted biologically significant regions of the sequence
• Standardized, full bibliographic data

GENESEQ is available via an EMBL-like FTP-delivered flat file, delivered every two weeks for inclusion in your in-house information system. An alternative option is the companion database GENESEQ™ FASTAlert that enables rapid searching of new sequences.

GENESEQ is available through leading sequence search and data management solutions including:

• GenomeQuest — integrated with the extended patent family coverage of GQ-Pat, so that you can find biological sequence information more accurately than ever
• STN International — suitable for advanced information searchers
• Thomson Pharma® — provides an at-a-glance view of the patent portfolios and activities of your competitors
  More information

GENESEQ FASTAlert is a companion database to GENESEQ and has been designed to act as an early warning system, enabling rapid searching of sequences to ensure exclusivity. Records contain essential information only and are published as quickly as possible, within two weeks of the patent publication date.

New sequences remain in GENESEQ FASTAlert until they are transferred to GENESEQ. At this point every sequence is annotated with the comprehensive information which is characteristic of GENESEQ.

With GENESEQ FASTAlert, you can:

• Access sequences months before they appear anywhere else GENESEQ FASTAlert brings you nucleic acid and amino acid sequences from patent documents within just two weeks of publication date.
• Perform accurate searches of patent data Data in GENESEQ FASTAlert are taken from printed patent documents, which contain the legally recognized version of sequences.
• Search data compiled by experts Sequences in GENESEQ FASTAlert are intellectually selected by Derwent's molecular genetics specialists to ensure novelty and relevance to therapeutic, diagnostics and other biotechnology research.

Why choose GENESEQ FASTAlert?

• New sequences from patent documents are added within two weeks of publication date. Updated with four to five thousand new sequences every week.
• Available in FASTA format.
• Each record contains: Patent Title; Patent Number; Patent Assignee; Patent Publication Date; Sequence Number, Earliest Priority Date; Database Entry Date; and the Sequence itself. In the first instance the Patent Title is the original patent title. The original patent title is updated to the Derwent Title when it becomes available. There is a qualifier field which lets you know when that has happened.
• Sequences in both GENESEQ and GENESEQ FASTAlert are taken from the full patent specification the legally recognized format.